Scientists Investigate Diabetic Ulcer Treatment

By IGI Global on Mar 31, 2011
Scientists believe that stem cell research has the potential to reveal treatments for a variety of human illnesses. According to FastCompany.com, researchers at New York University Medical Center, in partnership with the Israeli company Pluristem Therapeutics, Inc. hope to test whether stem cells from human placentas can help relieve Diabetic ulcers, a common complication of diabetes which can necessitate amputation. FastCompany.com describes itself as "the world's leading progressive business media brand, with a unique editorial focus on innovation in technology, ethonomics (ethical economics), leadership, and design" that is "written for, by, and about the most progressive business leaders…"
"[Pluristem's] latest project is a preclinical trial at New York University to test whether placenta-derived stem cells can be used to treat diabetic foot ulcers," writes Neal Ungerleider for FastCompany.com on March 29. "… Doctors at NYU are hoping that the stem cells can help successfully grow new blood vessels from pre-existing blood vessels in patients' feet and to help aid in tissue regeneration." According to the Israeli Globes, a business daily publication, the U.S. National Institutes of Health plan to support this study. Dr. Weiliam Chen, Director of NYU's Tissue Engineering Research Laboratory, told Globes that Pluristem's PLX cells "can stimulate angiogenesis, which is highly advantageous in treating diabetic chronic wounds" and are able to "directly address cellular impairment in diabetic wounds."
"No new therapy for diabetic chronic wounds has been introduced into clinical use since 1998 and there is a critical unmet need for innovative therapies able to accelerate diabetic foot ulcer healing, prevent amputation and reduce associated morbidity and mortality," argues Dr. Chen, who will be the principal investigator on this study.
"It is important to note that Pluristem's method of extracting stem cells from the placenta does not involve embryos in any way," writes Ungerleider at FastCompany.com. Experimentation using tissues from placenta cells is significantly less controversial than research on embryonic stem cells.
For more research on stem cells, you can visit the National Institutes of Health Stem Cell Unit Web page.

IGI Global publishes a number of books on Biomedical Technologies as well as the ethical issues surrounding health care decisions. Those interested in biomedical advancements and other health care topics might be interested several of our forthcoming titles: For additional research, check out our Nursing and Clinical Technologies topic collection.

Browse for more posts in:
HealthcareMedical, Healthcare, and Life SciencesBiomedical Technologies

No comments Comments

Log in or sign up to comment.
Be the first to comment!

More from IGI Global

Despite increasing acceptance and legalization of cannabis in some US states, disparities persist in federal marijuana laws, exacerbated by the Biden administration's classification of cannabis as a Schedule I drug. This inconsistency leads to unfair penalties in the criminal justice system, where individuals in legal states can still face federal prosecution.
IGI GlobalRead More
Medical, Healthcare, and Life SciencesBooks & E-BooksResearch Trends
Google has recently introduced its new Gemini platform, which competes with OpenAI's ChatGPT. This platform promises to provide real-time chat with advanced algorithms to meet the increasing demand for instant AI interactions.
IGI GlobalRead More
Computer Science and Information TechnologyArtificial IntelligenceBooks & E-BooksResearch Trends
How can advertisers possibly keep up with billions of unique individuals on the planet? Enter artificial intelligence.
IGI GlobalRead More
Business and ManagementMarketingBooks & E-BooksResearch Trends
In its second year, the IGI Global Annual Academic Publishing Trends & Open Access Survey 2024 seeks to create a realistic outlook on problems faced by the academic community and their potential solutions.
IGI GlobalRead More
Resources for LibrariansResources for ResearchersOpen Access
The World Health Organization (WHO) has reported a surge in Lassa fever cases in Nigeria, emphasizing the urgent need for containment measures.
IGI GlobalRead More
Medical, Healthcare, and Life SciencesHealthcare Information SystemsBooks & E-BooksResearch Trends
IGI Global congratulates the winners of this year's Journal Reviewer Award
IGI GlobalRead More
JournalsAwards & RecognitionOpen Access
For decades, academic publishing has been plagued with discrepancies surrounding authorship of scholarly research...
IGI GlobalRead More
Books & E-BooksAcquisitions
Two IGI Global publications have been recognized by Doody's for their excellence and niche topic focus.
IGI GlobalRead More
Medical, Healthcare, and Life SciencesMedia and CommunicationsBooks & E-BooksAwards & Recognition
Digital Inclusion Week underscored the urgent need for a national digital equity plan in the US due to disparities in internet access and digital skills.
IGI GlobalRead More
The majority of IGI Global's books Frontlist is now indexed by Scopus. Learn what this prestigious recognition means for the publisher and the experts behind these books.
IGI GlobalRead More
Books & E-BooksAwards & RecognitionReviews & Indexing
First Previous 1 2 3 4 5 6 7 8 9 10  ... Next Last